These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 33179087)
1. Curcumin attenuates lncRNA H19‑induced epithelial‑mesenchymal transition in tamoxifen‑resistant breast cancer cells. Cai J; Sun H; Zheng B; Xie M; Xu C; Zhang G; Huang X; Zhuang J Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179087 [TBL] [Abstract][Full Text] [Related]
2. HHLA2 promotes tumor progression by long non‑coding RNA H19 in human gallbladder cancer. Zhang Y; Li H; Lv C; Wu B; Yu Y; Zhong C; Lang Q; Liang Z; Li Y; Shi Y; Zhang J; Xu F; Tian Y Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35920182 [TBL] [Abstract][Full Text] [Related]
3. The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy. Wang J; Xie S; Yang J; Xiong H; Jia Y; Zhou Y; Chen Y; Ying X; Chen C; Ye C; Wang L; Zhou J J Hematol Oncol; 2019 Jul; 12(1):81. PubMed ID: 31340867 [TBL] [Abstract][Full Text] [Related]
4. H19/let‑7/Lin28 ceRNA network mediates autophagy inhibiting epithelial‑mesenchymal transition in breast cancer. Xiong H; Shen J; Chen Z; Yang J; Xie B; Jia Y; Jayasinghe U; Wang J; Zhao W; Xie S; Wang L; Zhou J Int J Oncol; 2020 Mar; 56(3):794-806. PubMed ID: 32124962 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan. Hiscox S; Baruha B; Smith C; Bellerby R; Goddard L; Jordan N; Poghosyan Z; Nicholson RI; Barrett-Lee P; Gee J BMC Cancer; 2012 Oct; 12():458. PubMed ID: 23039365 [TBL] [Abstract][Full Text] [Related]
6. Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells. Lombardo Y; Faronato M; Filipovic A; Vircillo V; Magnani L; Coombes RC Breast Cancer Res; 2014 Jun; 16(3):R62. PubMed ID: 24919951 [TBL] [Abstract][Full Text] [Related]
7. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT. Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718 [TBL] [Abstract][Full Text] [Related]
8. Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells. Zhang W; Zhou K; Zhang X; Wu C; Deng D; Yao Z Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649811 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA SOX2OT in tamoxifen-resistant breast cancer. Lee J; Kim EA; Kang J; Chae YS; Park HY; Kang B; Lee SJ; Lee IH; Park JY; Park NJ; Jung JH BMC Mol Cell Biol; 2024 Apr; 25(1):12. PubMed ID: 38649821 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells. Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678 [TBL] [Abstract][Full Text] [Related]
11. Knockdown of long non‑coding RNA DDX11‑AS1 inhibits the proliferation, migration and paclitaxel resistance of breast cancer cells by upregulating microRNA‑497 expression. Liang M; Zhu B; Wang M; Jin J Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35169864 [TBL] [Abstract][Full Text] [Related]
12. Curcumin decreases epithelial‑mesenchymal transition by a Pirin‑dependent mechanism in cervical cancer cells. Aedo-Aguilera V; Carrillo-Beltrán D; Calaf GM; Muñoz JP; Guerrero N; Osorio JC; Tapia JC; León O; Contreras HR; Aguayo F Oncol Rep; 2019 Nov; 42(5):2139-2148. PubMed ID: 31436299 [TBL] [Abstract][Full Text] [Related]
13. EGFR inhibition reverses epithelial‑mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells. Takeda T; Tsubaki M; Matsuda T; Kimura A; Jinushi M; Obana T; Takegami M; Nishida S Oncol Rep; 2022 Jun; 47(6):. PubMed ID: 35445730 [TBL] [Abstract][Full Text] [Related]
14. The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer. Loh YN; Hedditch EL; Baker LA; Jary E; Ward RL; Ford CE BMC Cancer; 2013 Apr; 13():174. PubMed ID: 23547709 [TBL] [Abstract][Full Text] [Related]
15. Long non‑coding RNA H19 regulates cell growth and metastasis via the miR‑22‑3p/Snail1 axis in gastric cancer. Gan L; Lv L; Liao S Int J Oncol; 2019 Jun; 54(6):2157-2168. PubMed ID: 31081061 [TBL] [Abstract][Full Text] [Related]
16. Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1. Li Y; Zhang Y; Liu X; Wang M; Wang P; Yang J; Zhang S Int J Oncol; 2018 Jun; 52(6):2119-2129. PubMed ID: 29620169 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells. Moon SY; Lee H; Kim S; Hong JH; Chun SH; Lee HY; Kang K; Kim HS; Won HS; Ko YH BMC Cancer; 2021 Aug; 21(1):931. PubMed ID: 34407787 [TBL] [Abstract][Full Text] [Related]
18. Astragalus polysaccharide inhibits breast cancer cell migration and invasion by regulating epithelial‑mesenchymal transition via the Wnt/β‑catenin signaling pathway. Yang S; Sun S; Xu W; Yu B; Wang G; Wang H Mol Med Rep; 2020 Apr; 21(4):1819-1832. PubMed ID: 32319619 [TBL] [Abstract][Full Text] [Related]
19. lncRNA FEZF1‑AS1 promotes migration, invasion and epithelial‑mesenchymal transition of retinoblastoma cells by targeting miR‑1236‑3p. Zhang G; Yang W; Li D; Li X; Huang J; Huang R; Luo J Mol Med Rep; 2020 Nov; 22(5):3635-3644. PubMed ID: 32901841 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition. Song R; Zhang J; Huang J; Hai T Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]